CHEMED CORP (CHE) Stock Analyst Ratings
USA - NYSE:CHE - US16359R1032 - Common Stock
436.62 USD
+1.23 (+0.28%)
436.62 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 88% to CHE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 590.07. This target is 35.14% above the current price.
CHE was analyzed by 8 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about CHE.
In the previous month the buy percentage consensus was at a similar level.
CHE was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-09-02 | Jefferies | Upgrade | Hold -> Buy |
| 2025-07-31 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-07-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-25 | Jefferies | Initiate | Hold |
| 2025-06-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-30 | B of A Securities | Maintains | Buy -> Buy |
| 2025-04-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-03-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-05-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-03-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-29 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-01-17 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-10-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-07-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-07-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-05-01 | RBC Capital | Maintains | Outperform |
| 2023-04-28 | Oppenheimer | Maintains | Outperform |
| 2023-02-27 | RBC Capital | Maintains | Outperform |
| 2022-11-03 | RBC Capital | Maintains | Outperform |
| 2022-08-01 | RBC Capital | Maintains | Outperform |
| 2022-04-28 | RBC Capital | Maintains | Outperform |
| 2022-03-04 | RBC Capital | Maintains | Outperform |
| 2021-07-29 | RBC Capital | Maintains | Outperform |
| 2021-02-25 | Oppenheimer | Maintains | Outperform |
CHEMED CORP / CHE FAQ
What is the price target for CHE stock?
8 analysts have analysed CHE and the average price target is 590.07 USD. This implies a price increase of 35.14% is expected in the next year compared to the current price of 436.62.
Can you provide the consensus rating for CHEMED CORP stock?
The consensus rating for CHEMED CORP (CHE) is 87.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover CHEMED CORP (CHE) stock?
The number of analysts covering CHEMED CORP (CHE) is 8.